2-[4-(2-Chloroacetyl)piperazin-1-yl]-2-phenylacetonitrile

Catalog No.: 
ACFSHM262
CAS No.: 
923155-13-9
Molecular Formula: 
C14H16ClN3O
Molecular Weight: 
277.76
2-[4-(2-Chloroacetyl)piperazin-1-yl]-2-phenylacetonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$65.00InquiryInquiry
100mg95%$97.00InquiryInquiry
250mg95%$136.00InquiryInquiry
1g95%$351.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(2-Chloroacetyl)piperazin-1-yl]-2-phenylacetonitrile
IUPAC Name2-(4-(2-chloroacetyl)piperazin-1-yl)-2-phenylacetonitrile
MDL No.MFCD08691135
Molecular FormulaC14H16ClN3O
Molecular Weight277.76
SMILESN#CC(N1CCN(C(CCl)=O)CC1)C2=CC=CC=C2
InChI KeyHDKMGPJGVSWJRE-UHFFFAOYSA-N
Synonym1-Piperazineacetonitrile, 4-(2-chloroacetyl)-α-phenyl-;2-[4-(2-Chloroacetyl)piperazin-1-yl]-2-phenylacetonitrile
CAS No.923155-13-9

Synthetic Route by SureRoute

1. ACFSHM262 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  6. Then
  7. ACFSHM262 route product structure diagram
    ACFSHM262923155-13-9
Inquiry

2. ACFSHM262 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFSHM262 route product structure diagram
    ACFSHM262923155-13-9
Inquiry

3. ACFSHM262 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFSHM262 route product structure diagram
    ACFSHM262923155-13-9
Inquiry

Comments (0)